DV
Dividend Vision

CARL — Carlsmed, Inc. Common Stock

Carlsmed, Inc. Common Stock (CARL)

Total return is -1.2% over the past 1.1 years, 25.0 points behind SPY at 23.8%. Its deepest 1-year drawdown was 48.0%.

Carlsmed, Inc. is a commercial-stage medical technology company that designs, manufactures, and markets AI-enabled personalized spine surgery solutions, centered on its aprevo platform, which combines proprietary surgical planning software with outcomes-based algorithms to create custom-built, anatomically designed vertebral interbody implants for spine fusion procedures. The company does not currently distribute dividends. Carlsmed appeals to investors seeking exposure to early-stage medical device innovation in the spine surgery market, rather than income-focused investors.

CARL key facts

Asset type
Stock
Asset class
Equity
Inception date
07/23/2025
Last close
$14.32
Market cap
$316,976,288
Average volume
77000.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.97